If I Could Invest in Just 1 ETF in 2026, Here's What I'd Buy

The article touts Invesco’s NASDAQ-100 ETF QQQM as the “best ETF to buy in 2026,” citing a lower 0.15% expense ratio vs QQQ’s 0.18% and strong five-year performance with 98% total return (vs 84% for VOO). It argues QQQM’s higher concentration in growth/tech (including Nvidia, Microsoft, Amazon, Apple, and Broadcom) should support larger long-term gains despite higher volatility than broad S&P 500 exposure. Overall, the piece is promotional/positioning-focused rather than driven by a discrete market-moving catalyst.

Analysis

This is more a positioning/flow story than a fundamentals catalyst. The only real market mechanism is incremental passive demand into the Nasdaq mega-cap complex, which mechanically supports NVDA, MSFT, AMZN, AAPL, and AVGO on a slow, price-insensitive basis; it does not create new earnings power. The flip side is that the trade implicitly deepens concentration risk: if crowded growth exposure unwinds, the same names will be the marginal source of drawdown in both ETF and single-name portfolios.

The biggest second-order point is that QQQM is a long-horizon wrapper, not a tactical vehicle. For trading, its lower fee is irrelevant versus liquidity, spreads, and options depth in QQQ; for retirement accounts, the fee edge matters only over years, so any AUM transfer is gradual rather than explosive. That means the immediate price impact should be muted; the real catalyst path is 1-3 months of continuing megacap leadership and stable/falling real yields, not this article itself.

Contrarian view: the consensus is overrating fee-minimization and underweighting regime risk. If rates stay higher for longer or breadth rotates into cyclicals/value on softer inflation, the Nasdaq-100's duration-sensitive multiple can compress faster than the S&P 500, making the "foreseeable future" outperformance thesis fragile. Falsifiers are a sustained rise in real yields, a pause in AI capex enthusiasm, or any regulatory shock that hits the top weights and breaks the concentration trade.

Key Decisions for Investors

• No direct trade in IVZ/QQQM on the headline alone; the signal is too weak and mostly retail-marketing driven. Wait for flow confirmation in fund data before treating this as a real AUM catalyst.
• If expressing the macro/flow view, stay long QQQ or NDX futures versus VOO for 3-6 months, but use QQQ rather than QQQM for execution because liquidity and options depth are materially better. Stop the trade if real yields resume rising or if the equal-weight/value rotation broadens beyond a 5-7% relative move.
• Own the underlying concentration beneficiaries on pullbacks: NVDA, MSFT, and AVGO remain the cleanest passive-flow recipients. The risk/reward is favorable only if 10-year real yields stay contained; a 50-75 bps move higher in real yields would likely negate the multiple support.
• Do not buy IVZ as a clean beneficiary; QQQM is likely cannibalizing QQQ rather than creating net-new economics. Reassess only if we see sustained net inflows into the Nasdaq franchise rather than internal share shift.
• For tactical hedging, pair long QQQ/short XLF or short equal-weight S&P via RSP if you expect continued mega-cap dominance. This is a 1-3 month relative-value trade; cover if breadth improves and financials/cyclicals start to outperform on lower-rate expectations.